Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson’s Disease1

Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review

(2015) Myria Petrou et al.   MOVEMENT DISORDERS

In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging

(2015) Jorge R. Barrio et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clock Drawing Test Ratings by Dementia Specialists: Interrater Reliability and Diagnostic Accuracy

(2014) Anil K. Nair et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

What can biomarkers tell us about cognition in Parkinson's disease?

(2014) Brit Mollenhauer et al.   MOVEMENT DISORDERS

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment

(2014) Eva Pirogovsky et al.   PARKINSONISM & RELATED DISORDERS

Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

(2013) Yaroslau Compta et al.   PARKINSONISM & RELATED DISORDERS

A -amyloid deposition in patients with Parkinson disease at risk for development of dementia

(2012) M. Petrou et al.   NEUROLOGY

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

(2012) S. N. Gomperts et al.   NEUROLOGY

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant

(2011) Elizabeth C. Mormino et al.   NEUROIMAGE

Towards a Pharmacophore for Amyloid

(2011) Meytal Landau et al.   PLOS BIOLOGY

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyloid imaging of Lewy body-associated disorders

(2010) Erin R. Foster et al.   MOVEMENT DISORDERS

Incidental Lewy body disease: Clinical comparison to a control cohort

(2010) Charles H. Adler et al.   MOVEMENT DISORDERS

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes

(2010) M.E. Kalaitzakis et al.   NEUROBIOLOGY OF DISEASE

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease

(2009) Yaroslau Compta et al.   MOVEMENT DISORDERS

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

(2009) Walter Maetzler et al.   NEUROBIOLOGY OF DISEASE

Imaging amyloid deposition in Lewy body diseases

(2008) S. N. Gomperts et al.   NEUROLOGY

[11C]PIB binding in Parkinson's disease dementia

(2007) Walter Maetzler et al.   NEUROIMAGE

[11C]-PIB imaging in patients with Parkinson's disease: Preliminary results

(2007) A. Johansson et al.   PARKINSONISM & RELATED DISORDERS